首页> 美国卫生研究院文献>Biochemical Journal >Human meprin alpha and beta homo-oligomers: cleavage of basement membrane proteins and sensitivity to metalloprotease inhibitors.
【2h】

Human meprin alpha and beta homo-oligomers: cleavage of basement membrane proteins and sensitivity to metalloprotease inhibitors.

机译:人meprinα和β同源寡聚体:基底膜蛋白的裂解和对金属蛋白酶抑制剂的敏感性。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Meprin is a zinc endopeptidase of the astacin family, which is expressed as a membrane-bound or secreted protein in mammalian epithelial cells, in intestinal leucocytes and in certain cancer cells. There are two types of meprin subunits, alpha and beta, which form disulphide-bonded homo- and hetero-oligomers. Here we report on the cleavage of matrix proteins by hmeprin (human meprin) alpha and beta homo-oligomers, and on the interactions of these enzymes with inhibitors. Despite their completely different cleavage specificities, both hmeprin alpha and beta are able to hydrolyse basement membrane components such as collagen IV, nidogen-1 and fibronectin. However, they are inactive against intact collagen I. Hence the matrix-cleaving activity of hmeprin resembles that of gelatinases rather than collagenases. Hmeprin is inhibited by hydroxamic acid derivatives such as batimastat, galardin and Pro-Leu-Gly-hydroxamate, by TAPI-0 (tumour necrosis factor alpha protease inhibitor-0) and TAPI-2, and by thiol-based compounds such as captopril. Therapeutic targets for these inhibitors are MMPs (matrix metalloproteases), TACE (tumour necrosis factor alpha-converting enzyme) and angiotensin-converting enzyme respectively. The most effective inhibitor of hmeprin alpha in the present study was the naturally occurring hydroxamate actinonin ( K(i)=20 nM). The marked variance in the cleavage specificities of hmeprin alpha and beta is reflected by their interaction with the TACE inhibitor Ro 32-7315, whose affinity for the beta subunit (IC50=1.6 mM) is weaker by three orders of magnitude than that for the alpha subunit ( K(i)=1.6 microM). MMP inhibitors such as the pyrimidine-2,4,6-trione derivative Ro 28-2653 that are more specific for gelatinases do not bind to hmeprin, presumably due to the subtle differences in the mode of zinc binding and active-site structure between the astacins and the MMPs.
机译:Meprin是Astacin家族的一种锌内肽酶,在哺乳动物上皮细胞,肠白细胞和某些癌细胞中以膜结合或分泌蛋白的形式表达。 meprin亚基有两种类型,α和β,它们形成二硫键结合的均聚物和杂聚物。在这里,我们报道了通过半胱氨酸(人类甲鱼精)α和β同源寡聚体对基质蛋白的裂解,以及这些酶与抑制剂的相互作用。尽管它们的切割特异性完全不同,但是半胱氨酸α和β都能够水解基底膜成分,例如胶原IV,尼古丁-1和纤连蛋白。但是,它们对完整的胶原蛋白I无活性。​​因此,乙丙啶的基质裂解活性类似于明胶酶而不是胶原酶。 Hmeprin受到巴马司他,加拉丁和Pro-Leu-Gly-异羟肟酸酯等异羟肟酸衍生物的抑制,被TAPI-0(肿瘤坏死因子α蛋白酶抑制剂-0)和TAPI-2抑制,并且被基于硫醇的化合物(如卡托普利)抑制。这些抑制剂的治疗靶分别是MMPs(基质金属蛋白酶),TACE(肿瘤坏死因子α转化酶)和血管紧张素转化酶。在本研究中,最有效的hmeprinα抑制剂是天然存在的异羟肟酸肌动蛋白(K(i)= 20 nM)。 hmeprinα和β切割特异性的显着差异反映在它们与TACE抑制剂Ro 32-7315的相互作用上,后者对β亚基(IC50 = 1.6 mM)的亲和力比对α弱3个数量级。亚基(K(i)=1.6μM)。 MMP抑制剂(例如嘧啶-2,4,6-三酮衍生物Ro 28-2653)对明胶酶更特异,但它们不与乙肝素结合,这可能是由于两者之间锌结合方式和活性位点结构的细微差异。葡萄球菌素和MMPs。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号